Equillium Inc. (EQ) |
|
5.13 0.05 (0.98%)
|
02-21 16:00 |
|
Open: |
5.15 |
Pre. Close: |
5.08 |
|
High:
|
5.6 |
Low:
|
4.98 |
|
Volume:
|
24,214 |
Market Cap:
|
89M |
|
|
|
|
Equillium, Inc., a biotechnology company, develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Its primary product candidate is EQ001, a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase 1b/2 clinical trials for the treatment of acute graft-versus-host disease; and Phase 1 clinical trial for the treatment of asthma and lupus nephritis. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was founded in 2017 and is headquartered in San Diego, California. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
5.607 - 5.63 |
5.63 - 5.652 |
|
Low:
|
4.929 - 4.952 |
4.952 - 4.973 |
|
Close:
|
5.093 - 5.129 |
5.129 - 5.164 |
|
Technical analysis |
as of: 2020-02-21 4:29:42 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 6.68 One year: 7.80 |
| Support: |
Support1: 4.59 Support2: 3.89 |
| Resistance: |
Resistance1: 5.72 Resistance2: 6.68 |
| Pivot: |
4.84  |
| Moving Average: |
MA(5): 5.05 MA(20): 4.88
MA(100): 4.09 MA(250): 5.02  |
| MACD: |
MACD(12,26): 0.16 Signal(9): 0.14 |
| Stochastic oscillator: |
%K(14,3): 67.89 %D(3): 69.33 |
| RSI: |
RSI(14): 61.44 |
| 52-week: |
High: 8.66 Low: 2.56 Change(%): -22.4 |
| Average Vol(K): |
3-Month: 4799 10-Days: 1977 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.EQ has closed below upper band by 18.8%. Bollinger Bands are 15% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 10 Dec 2019 21:07:02 +0000
Health Care Sector Update for 12/10/2019: XAIR,LVGO,EQ,CRL
Tue, 10 Dec 2019 18:48:41 +0000
Health Care Sector Update for 12/10/2019: LVGO,EQ,CRL
Tue, 10 Dec 2019 14:09:29 +0000
Health Care Sector Update for 12/10/2019: EQ, SUPN, SNY, JNJ, ABT, PFE, MRK, AMGN
Wed, 07 Aug 2019 04:38:16 +0000
5 Top Losers In Healthcare Sector (ENDP, AVGR, LPTX...)
Tue, 21 May 2019 21:28:08 +0000
5 Top Gainers In Pharma Sector (ARRY, EQ, ARWR...)
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqGS |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
17.38 |
| Shares Float (M) |
4.98 |
|
% Held by Insiders
|
18.44 |
|
% Held by Institutions
|
0.73 |
|
Shares Short (K)
|
122 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-1.347 |
|
Book Value (p.s.)
|
2.820 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-42.0 |
|
Return on Equity (ttm)
|
-119.4 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-1.342 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-17.74 |
|
Levered Free Cash Flow (M)
|
-11.81 |
Stock Valuations |
|
P/E
|
-3.81 |
|
P/E Growth Ratio
|
0.01 |
|
P/BV
|
1.82 |
|
P/S
|
|
|
P/CF
|
-5.03 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
